Champions Oncology Inc
NASDAQ:CSBR 4:00:00 PM EDT
| Market Cap (Intraday) | 101.90M |
| Current PE | 15.85 |
| Forward PE | 24.57 |
| 2yr Forward PE | 33.5 |
| 10-Day MA | $7.55 |
| 50-Day MA | $6.81 |
| 200-Day MA | $7.16 |
Champions Oncology Inc Stock, NASDAQ:CSBR
One University Plaza, Suite 307, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.808.8400
Number of Employees: 210
Description
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.